CEO Amit Etkin was paid $2,188,487 in fiscal year 2025 (SEC filing 0001104659-26-035180 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$2,188,487 Amit Etkin total, FY2025 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | — Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
ANRO's next annual pay disclosure, estimated March 26, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Amit Etkin | $650,671 | $220,000 | $0 | $934,186 | $358,072 | $0 | $25,558 | $2,188,487 |
| President, Chief Executive Officer, and Chair of the Board | ||||||||
| Nicholas Smith | 493,720 | 220,000 | 0 | 594,723 | 222,300 | 0 | 10,842 | 1,541,585 |
| Chief Financial Officer and Chief Business Officer | ||||||||
| Michael Hanley | 488,800 | 0 | 0 | 517,598 | 195,520 | 0 | 11,010 | 1,212,928 |
| Chief Operating Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Amit Etkin | $2,188,487 | $4,065,848 | — | ↓ −1,877,361 |
| Nicholas Smith | 1,541,585 | 1,995,964 | — | ↓ −454,379 |
| Michael Hanley | 1,212,928 | 2,442,628 | — | ↓ −1,229,700 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Alto Neuroscience's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper ANRO reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses ANRO in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ANRO in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Andrew Dreyfus | Independent Director | $80,263 |
| Christopher Nixon Cox | Lead Independent Director | $110,543 |
| Gwill York | Independent Director | $88,178 |
| Husseini Manji, M.D | Independent Director | $73,129 |
| Maha Radhakrishnan, M.D | Former director (through FY2025) | $17,906 |
| Po Yu (Jeff) Chen, Ph.D | Former director (through FY2025) | $19,747 |
| Raymond Sanchez, M.D | Independent Director | $84,904 |
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Nicholas Smith | Option | 135,000 | 4.2 | — |
| Nicholas Smith | RSU | 24,670 | — | 9,163 |
| Amit Etkin | RSU | 215,000 | — | 107,502 |
| Amit Etkin | RSU | 97,563 | — | 48,782 |
| Nicholas Smith | RSU | 39,375 | — | 19,688 |
| Amit Etkin | RSU | 164,859 | — | 82,431 |
| Michael Hanley | Option | 125,000 | 4.2 | — |
| Michael Hanley | RSU | 74,417 | — | 113,583 |
| Nicholas Smith | RSU | 134,886 | — | 67,443 |
| Nicholas Smith | RSU | 36,531 | — | 8,431 |
| Michael Hanley | RSU | 8,000 | — | 12,210 |
| Amit Etkin | RSU | 25,243 | — | 9,377 |
The company's compensation philosophy is designed to align the interests of named executive officers with those of stockholders by providing a fixed base salary reflecting skill and market levels, annual incentive compensation based on individual and corporate performance, and equity-based awards that serve as retention measures and incentivize the achievement of corporate goals.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon Consulting, Inc. |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Christopher Nixon CoxIndependent · Lead Independent Director · Audit · Compensation (Chair) · Nominating and Corporate Governance | $4,390 | — | $106,153 | — | — | $110,543 |
| Gwill YorkIndependent · Audit (Chair) · Compensation | 0 | — | 88,178 | — | — | 88,178 |
| Raymond Sanchez, M.DIndependent · Nominating and Corporate Governance | 8,682 | — | 76,222 | — | — | 84,904 |
| Andrew DreyfusIndependent · Audit · Compensation | 54,000 | — | 26,263 | — | — | 80,263 |
| Husseini Manji, M.DIndependent · Nominating and Corporate Governance (Chair) | 1,929 | — | 71,200 | — | — | 73,129 |
| Po Yu (Jeff) Chen, Ph.DIndependent · Departed during FY | 19,747 | — | 0 | — | — | 19,747 |
| Maha Radhakrishnan, M.DIndependent · Departed during FY | 17,906 | — | 0 | — | — | 17,906 |
| Amit Etkin, M.D., Ph.DEmployee director · Board Chair | — | — | — | — | — | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 16,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $106,654 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $106,654 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Alto Neuroscience | 2025 | Amit Etkin | $650,671 | $0 | $934,186 | $358,072 | $2,188,487 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Amit Etkin | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Summary Compensation Table”. As printed: 2,188,487. Filing ↗machine: r1 · c47 · span 533298–533307 |
| 2 | Section 01, Nicholas Smith | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Summary Compensation Table”. As printed: 1,541,585. Filing ↗machine: r3 · c47 · span 542740–542749 |
| 3 | Section 01, Michael Hanley | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Summary Compensation Table”. As printed: 1,212,928. Filing ↗machine: r5 · c47 · span 552122–552131 |
| 4 | Section 07, pay ratio | 10-K | 2026-03-16 | 0001999480-26-000002 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 5 | Section 08, Christopher Nixon Cox | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Director Compensation”. As printed: 110,543. Filing ↗machine: span 276020–276027 |
| 6 | Section 08, Gwill York | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Director Compensation”. As printed: 88,178. Filing ↗machine: span 286113–286119 |
| 7 | Section 08, Raymond Sanchez, M.D | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Director Compensation”. As printed: 84,904. Filing ↗machine: span 284511–284517 |
| 8 | Section 08, Andrew Dreyfus | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Director Compensation”. As printed: 80,263. Filing ↗machine: span 278127–278133 |
| 9 | Section 08, Husseini Manji, M.D | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Director Compensation”. As printed: 73,129. Filing ↗machine: span 280213–280219 |
| 10 | Section 08, Po Yu (Jeff) Chen, Ph.D | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Director Compensation”. As printed: 19,747. Filing ↗machine: span 272920–272926 |
| 11 | Section 08, Maha Radhakrishnan, M.D | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Director Compensation”. As printed: 17,906. Filing ↗machine: span 281416–281422 |
| 12 | Section 08, Amit Etkin, M.D., Ph.D | DEF 14A | 2026-03-26 | 0001104659-26-035180 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 13 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 14 | Section 09b board cost (computed) | Computed | — | — | Cash 106,654 + equity 0 + all other 0 = 106,654, summed across the director compensation table rows.machine: formula: Σ = 106,654 |
| 15 | Alto Neuroscience (subject), Section 10b CEO total | DEF 14A | 2026-03-26 | 0001104659-26-035180 | CEO total compensation as printed in Alto Neuroscience's own proxy. As printed: 2,188,487. Filing ↗machine: r1 · c47 · span 533298–533307 |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.